{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T11:15:54Z","timestamp":1767179754189,"version":"build-2238731810"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2012,4,5]],"date-time":"2012-04-05T00:00:00Z","timestamp":1333584000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1002457","type":"journal-article","created":{"date-parts":[[2012,4,5]],"date-time":"2012-04-05T16:50:30Z","timestamp":1333644630000},"page":"e1002457","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":31,"title":["Automatic Filtering and Substantiation of Drug Safety Signals"],"prefix":"10.1371","volume":"8","author":[{"given":"Anna","family":"Bauer-Mehren","sequence":"first","affiliation":[]},{"given":"Erik M.","family":"van Mullingen","sequence":"additional","affiliation":[]},{"given":"Paul","family":"Avillach","sequence":"additional","affiliation":[]},{"given":"Mar\u00eda del Carmen","family":"Carrascosa","sequence":"additional","affiliation":[]},{"given":"Ricard","family":"Garcia-Serna","sequence":"additional","affiliation":[]},{"given":"Janet","family":"Pi\u00f1ero","sequence":"additional","affiliation":[]},{"given":"Bharat","family":"Singh","sequence":"additional","affiliation":[]},{"given":"Pedro","family":"Lopes","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 L.","family":"Oliveira","sequence":"additional","affiliation":[]},{"given":"Gayo","family":"Diallo","sequence":"additional","affiliation":[]},{"given":"Ernst","family":"Ahlberg Helgee","sequence":"additional","affiliation":[]},{"given":"Scott","family":"Boyer","sequence":"additional","affiliation":[]},{"given":"Jordi","family":"Mestres","sequence":"additional","affiliation":[]},{"given":"Ferran","family":"Sanz","sequence":"additional","affiliation":[]},{"given":"Jan A.","family":"Kors","sequence":"additional","affiliation":[]},{"given":"Laura I.","family":"Furlong","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2012,4,5]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/446975a","article-title":"When good drugs go bad.","volume":"446","author":"KM Giacomini","year":"2007","journal-title":"Nature"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1001\/jama.279.15.1200","article-title":"Incidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-analysis of Prospective Studies.","volume":"279","author":"J Lazarou","year":"1998","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2165\/00002018-200629020-00006","article-title":"Adverse drug reaction-related hospitalisations: a nationwide study in The Netherlands.","volume":"29","author":"CS van der Hooft","year":"2006","journal-title":"Drug Saf"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1472-6963-11-9","article-title":"Health care use and costs of adverse drug events emerging from outpatient treatment in Germany: a modelling approach.","volume":"11","author":"RG Stark","year":"2011","journal-title":"BMC Health Serv Res"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1258\/jrsm.2010.100113","article-title":"Ten-year trends in hospital admissions for adverse drug reactions in England 1999\u20132009.","volume":"103","author":"TY Wu","year":"2010","journal-title":"J R Soc Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00228-008-0475-9","article-title":"Pharmacovigilance: methods, recent developments and future perspectives.","volume":"64","author":"L H\u00e4rmark","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"key":"ref7","first-page":"43","article-title":"The EU-ADR project: preliminary results and perspective.","volume":"148","author":"G Trifiro","year":"2009","journal-title":"Stud Health Technol Inform"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pds.2053","article-title":"Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EU-ADR Project.","volume":"20","author":"PM Coloma","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.2217\/14622416.8.11.1479","article-title":"\u2018Drug reactions, enzymes, and biochemical genetics\u2019: 50 years later.","volume":"8","author":"D Gurwitz","year":"2007","journal-title":"Pharmacogenomics"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0031-6997(25)06872-3","article-title":"Drug-induced hemolytic anemia.","volume":"21","author":"E Beutler","year":"1969","journal-title":"Pharmacol Rev"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S1359-6446(03)03008-3","article-title":"Predicting undesirable drug interactions with promiscuous proteins in silico.","volume":"9","author":"S Ekins","year":"2004","journal-title":"Drug Discov Today"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/newbio231232a0","article-title":"Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.","volume":"231","author":"JR Vane","year":"1971","journal-title":"Nat New Biol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s000110050291","article-title":"Cyclooxygenase selectivity and the risk of gastro-intestinal complications of various non-steroidal anti-inflammatory drugs: A clinical consideration.","volume":"47","author":"S Kawai","year":"1998","journal-title":"Inflamm Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1001\/jama.287.13.1690","article-title":"Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy.","volume":"287","author":"MK Higashi","year":"2002","journal-title":"JAMA"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/clpt.2008.274","article-title":"Data-Driven Methods to Discover Molecular Determinants of Serious Adverse Drug Events.","volume":"85","author":"AP Chiang","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e1000433","DOI":"10.1371\/journal.pgen.1000433","article-title":"A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose.","volume":"5","author":"F Takeuchi","year":"2009","journal-title":"PLoS Genet"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/sj.bjp.0705146","article-title":"Brain CYP2E1 is induced by nicotine and ethanol in rat and is higher in smokers and alcoholics.","volume":"138","author":"LA Howard","year":"2003","journal-title":"Br J Pharmacol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/1471-2105-8-S3-S2","article-title":"Advancing translational research with the Semantic Web.","volume":"8","author":"A Ruttenberg","year":"2007","journal-title":"BMC Bioinformatics"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jbi.2006.02.007","article-title":"Data integration and genomic medicine.","volume":"40","author":"B Louie","year":"2007","journal-title":"J Biomed Inf"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nrg1872","article-title":"Addressing the problems with life-science databases for traditional uses and systems biology.","volume":"7","author":"S Philippi","year":"2006","journal-title":"Nat Rev Genet"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/bib\/bbp024","article-title":"Biological knowledge management: the emerging role of the Semantic Web technologies.","volume":"10","author":"EZ Antezana","year":"2009","journal-title":"Brief Bioinform"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/nbt0908-983","article-title":"Data completeness\u2013the Achilles heel of drug-target networks.","volume":"26","author":"J Mestres","year":"2008","journal-title":"Nat Biotechnol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1109\/MC.2007.421","article-title":"Examining the Challenges of Scientific Workflows.","volume":"40","author":"Y Gil","year":"2007","journal-title":"Computer"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1093\/bioinformatics\/bth361","article-title":"Taverna: a tool for the composition and enactment of bioinformatics workflows.","volume":"20","author":"T Oinn","year":"2004","journal-title":"Bioinformatics"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.1158140","article-title":"Drug target identification using side-effect similarity.","volume":"321","author":"M Campillos","year":"2008","journal-title":"Science"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks.","volume":"13","author":"P Shannon","year":"2003","journal-title":"Genome Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"D901","DOI":"10.1093\/nar\/gkm958","article-title":"DrugBank: a knowledgebase for drugs, drug actions and drug targets.","volume":"36","author":"DS Wishart","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa0806994","article-title":"Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac Death.","volume":"360","author":"WA Ray","year":"2009","journal-title":"New Engl J Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0920-9964(01)00325-5","article-title":"Neuroleptics and mortality in schizophrenia: prospective analysis of deaths in a French cohort of schizophrenic patients.","volume":"57","author":"C Montout","year":"2002","journal-title":"Schizophr Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1192\/apt.12.1.35","article-title":"Sudden cardiac death and antipsychotics. Part 1: Risk factors and mechanisms.","volume":"12","author":"N Abdelmawla","year":"2006","journal-title":"Adv Psychiatr Treat"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.vascn.2005.07.003","article-title":"Are hERG channel inhibition and QT interval prolongation all there is in drug-induced torsadogenesis? A review of emerging trends.","volume":"53","author":"P Hoffmann","year":"2006","journal-title":"J Pharmacol Toxicol Methods"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"ra30","DOI":"10.1126\/scisignal.2000723","article-title":"Systems pharmacology of arrhythmias.","volume":"3","author":"SI Berger","year":"2010","journal-title":"Science Signaling"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1517\/14740338.7.2.181","article-title":"Sudden cardiac death secondary to antidepressant and antipsychotic drugs.","volume":"7","author":"S Sicouri","year":"2008","journal-title":"Expert Opin Drug Saf"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1073\/pnas.0609278104","article-title":"KCNQ potassium channel mutations cause cardiac arrhythmias in Drosophila that mimic the effects of aging.","volume":"104","author":"K Ocorr","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1371\/journal.pcbi.0030217","article-title":"In silico elucidation of the molecular mechanism defining the adverse effect of selective estrogen receptor modulators.","volume":"3","author":"L Xie","year":"2007","journal-title":"PLoS Comp Biol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"D267","DOI":"10.1093\/nar\/gkh061","article-title":"The Unified Medical Language System (UMLS): integrating biomedical terminology.","volume":"32","author":"O Bodenreider","year":"2004","journal-title":"Nucl Acids Res"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1353\/pbm.1986.0087","article-title":"Fish oil, Raynaud's syndrome, and undiscovered public knowledge.","volume":"30","author":"DR Swanson","year":"1986","journal-title":"Perspect Biol Med"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1517\/17425255.2010.509343","article-title":"Anticipating drug side effects by comparative pharmacology.","volume":"6","author":"R Garcia-Serna","year":"2010","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1093\/bioinformatics\/btq538","article-title":"DisGeNET: a Cytoscape plugin to visualize, integrate, search and analyze gene-disease networks.","volume":"26","author":"A Bauer-Mehren","year":"2010","journal-title":"Bioinformatics"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF00279225","article-title":"Phenocopy.","volume":"9","author":"W Lenz","year":"1970","journal-title":"Hum Genet"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1002\/humu.21106","article-title":"The genetic basis of long QT and short QT syndromes: a mutation update.","volume":"30","author":"PL Hedley","year":"2009","journal-title":"Hum Mutat"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/HCO.0b013e32801129eb","article-title":"Drug-induced long QT and torsade de pointes: recent advances.","volume":"22","author":"PJ Kannankeril","year":"2007","journal-title":"Curr Opin Cardiol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1139\/y98-153","article-title":"Haloperidol-mediated phosphoinositide hydrolysis via direct activation of alpha1-adrenoceptors in frontal cerebral rat cortex.","volume":"77","author":"TG Borda","year":"1999","journal-title":"Can J Physiol Pharmacol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/CVM-2-5-205","article-title":"Withdrawal of cerivastatin from the world market.","volume":"2","author":"CD Furberg","year":"2001","journal-title":"Curr Control Trials Cardiovasc Med"},{"key":"ref45","article-title":"Drug Toxicity. Pharmacology: The Pathophysiologic Basis of Drug Therapy. 2 ed","author":"CM Taniguchi","year":"2007"},{"key":"ref46","first-page":"1085","article-title":"Design and evaluation of a semantic approach for the homogeneous identification of events in eight patient databases: a contribution to the European EU-ADR project.","volume":"160","author":"P Avillach","year":"2010","journal-title":"Stud Health Technol Inform"},{"key":"ref47","first-page":"131","article-title":"Peregrine: Lightweight gene name normalization by dictionary lookup.","author":"MJ Schuemie","year":"2007"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"R39","DOI":"10.1186\/gb-2007-8-3-r39","article-title":"Reactome: a knowledge base of biologic pathways and processes.","volume":"8","author":"I Vastrik","year":"2007","journal-title":"Genome Biol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/msb.2009.47","article-title":"Pathway databases and tools for their exploitation: benefits, current limitations and challenges.","volume":"5","author":"A Bauer-Mehren","year":"2009","journal-title":"Mol Syst Biol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1074\/mcp.M500279-MCP200","article-title":"A Human Protein Atlas for Normal and Cancer Tissues Based on Antibody Proteomics.","volume":"4","author":"M Uhl\u00e9n","year":"2005","journal-title":"Mol Cell Proteomics"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1002\/pds.1836","article-title":"Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor?","volume":"18","author":"G Trifiro","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref52","first-page":"190","article-title":"A semantic approach for the homogeneous identification of events in eight patient databases: a contribution to the European eu-ADR project.","volume":"150","author":"P Avillach","year":"2009","journal-title":"Stud Health Technol Inform"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"763","DOI":"10.2174\/1568026054637665","article-title":"Chemical and biological profiling of an annotated compound library directed to the nuclear receptor family.","volume":"5","author":"M Cases","year":"2005","journal-title":"Curr Top Med Chem"}],"updated-by":[{"DOI":"10.1371\/annotation\/695450aa-95a0-491d-804d-470cbfa861e8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2012,5,4]],"date-time":"2012-05-04T00:00:00Z","timestamp":1336089600000}}],"container-title":["PLoS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pcbi.1002457","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T11:01:08Z","timestamp":1742900468000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1002457"}},"subtitle":[],"editor":[{"given":"Russ B.","family":"Altman","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2012,4,5]]},"references-count":53,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2012,4,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1002457","relation":{},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,5]]}}}